Inotiv, Inc. will announce the third quarter

WEST LAFAYETTE, Indiana, Aug. 01, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. ( NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in non-clinical and analytical drug discovery and development services and research models and related products and services, announced today that the Company will issue its press release on Wednesday on the financial results for the third quarter of fiscal 2022 ended June 30, 2022, on August 10, 2022, after the close of trading. The Company will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

Interested parties may participate in the call by dialing:

  • (877) 407-9753 (domestic)
  • (201) 493-6739 (International)

The webcast of the live conference call will be accessible on the Investors section of the Company’s website and directly via the following link:

For those unable to listen to the live stream, an online replay will be available in the Investors section of the Inotiv website at:

About Inotiv

Inotiv, Inc. is a leading contract research organization dedicated to providing non-clinical and analytical services in drug discovery and development, research models and related products and services. The Company’s products and services aim to bring new drugs and medical devices through the discovery and preclinical development phases, while increasing efficiency, improving data and reducing the cost of bringing new products to market. medications. Inotiv is committed to supporting discovery and development goals as well as helping researchers realize the full potential of their critical R&D projects, while working together to build a healthier and safer world. You can find more information about Inotiv here:

This release may contain forward-looking statements that are subject to risks and uncertainties, including, but not limited to, risks and uncertainties relating to changes in the market and demand for our products and services, the development, marketing and sale of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the success of their closing, their integration and their commercial and financial impact, government regulations, inspections and investigations, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in Company filings with the United States Securities and Exchange Commission.

Company details Investor Relations
Inotiv, Inc. The Equity Group, Inc.
Beth A. Taylor, Chief Financial Officer Devin Sullivan
(765) 497-8381 (212) 836-9608
[email protected] [email protected]


Comments are closed.